Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

Estrogen and androgen signals control synaptic changes in rat brains.

Minoxidil needs specific structure to block lysyl hydroxylase; exploring alternatives may keep benefits without this effect.

Hair follicles are valuable for regenerative medicine and wound healing.

Prostaglandin D₂ might be targeted for new male pattern baldness treatments.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Pyrene excimer nucleic acid probes are promising for detecting biomolecules accurately with potential for biological research and drug screening.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

A gene in Sebekia benihana, CYP-sb21, is needed for a specific reaction on the drug Cyclosporine A, which could be important for hair growth without affecting the immune system.

A new compound shows promise as a topical treatment for hair loss.

Researchers developed a quick and sensitive way to measure finasteride in blood using a small sample size.

Some people have a genetic variation that makes them less effective at breaking down drugs.

New treatment improves male hair loss.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.

Certain substances that block a specific protein help promote hair growth.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

New hybrid compound found to effectively prevent hair loss.

Current research explores hair growth drugs, while future research aims for personalized treatments.

Protoporphyrin IX is useful in cancer treatment but can cause health problems if not properly regulated.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Mouse skin can produce and process serotonin, with variations depending on hair cycle, body location, and mouse strain.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.